Should we recommend the COVID-19 booster vaccine to patients who had a DVT or any other complications such as hemolytic anemia or thrombocytopenia from prior vaccine doses?

Topics: Pediatric Oncology • Rheumatology • Thrombosis • COVID-19 • Hematology • Pediatric Hematology • Benign Hematology • Hemostasis/Thrombosis • COVID-19 virus

Answer from: at Academic Institution

There are a few case reports of VTE following COVID-19 vaccinations (approximately 10 based on my PubMed review today). However, VTE has a high incidence of 0.1% in the general population and much higher after age 45 (Mary Cushman, PMID 17433897), so determining a causal relationship between the vac...

Comments

Medical Oncologist at Ironwood Cancer & Research Center
Thank you for your informative discussion. I agree...

at UT Southwestern Medical Center
I agree with this excellent assessment of the curr...

Answer from: Medical Oncologist at Academic Institution

We have had several instances of severe thrombocytopenia (platelets 1K) following the vaccine. Hard to convince the patient (let alone ourselves) to go for a booster; perhaps administer Evusheld as an alternative?

Related Questions